Objective Based on the localization of resource-based relative value scale (RBRVS) in H Hospital, to implement a surgical performance management model reform with the main surgery as the core, and to construct a more scientific and fair surgical performance distribution system. Methods A surgical performance management model with the main surgery as the core was constructed. Relevant data such as RBRVS, diagnosis related groups (DRG), case mixed index (CMI), and surgical time of 65 915 inpatient elective surgeries in H Hospital in 2023 were collected and organized. Large sample historical data analysis was conducted using SPSS software, and the rationality of the optimized surgical performance management model was verified through key indicators. Results The total coefficient of multiple orders for surgery in the 22 departments included in the study was highly correlated with the main surgery coefficient (γ>0.85), and the matching coefficients for each specialty were significantly different (P<0.001). The surgical performance management model with the main surgery as the core showed a significant improvement in the key indicators (doctor’s time resource investment and surgical risk and difficulty). Conclusion By implementing a surgical performance management model with the main surgery as the core, we aim to strengthen the performance orientation that reflects the risks and difficulty of diagnosis and treatment, as well as the value of doctor services. This will guide clinical practice to return to the essence of medicine, support the development of discipline construction, and further stimulate the vitality and motivation of clinical work.
Citation:
WU Qinyi, WANG Jun, XU Xu, SONG Wenjie, WEN Limin. Empirical study on surgical performance management model based on RBRVS with main surgery as the core. Chinese Journal of Evidence-Based Medicine, 2024, 24(8): 899-903. doi: 10.7507/1672-2531.202406074
Copy
Copyright © the editorial department of Chinese Journal of Evidence-Based Medicine of West China Medical Publisher. All rights reserved
1. |
石应康, 程永忠. 从垂直管理到合纵连横. 北京: 人民卫生出版社, 2013.
|
2. |
|
3. |
Hsiao WC, Braun P, Dunn DL, et al. An overview of the development and refinement of the resource-based relative value scale. The foundation for reform of U. S. physician payment. Med Care, 1992, 30(11 Suppl): NS1-NS12.
|
4. |
|
5. |
|
6. |
|
7. |
余淳, 罗琳, 杨翠, 等. 高质量发展背景下的大型综合医院人力资源合理配置. 成都: 四川大学出版社, 2024.
|
8. |
|
9. |
|
10. |
国务院办公厅. 关于进一步深化基本医疗保险支付方式改革的指导意见(国办发〔2017〕55号). 2017.
|
11. |
|
12. |
|
13. |
|
- 1. 石应康, 程永忠. 从垂直管理到合纵连横. 北京: 人民卫生出版社, 2013.
- 2.
- 3. Hsiao WC, Braun P, Dunn DL, et al. An overview of the development and refinement of the resource-based relative value scale. The foundation for reform of U. S. physician payment. Med Care, 1992, 30(11 Suppl): NS1-NS12.
- 4.
- 5.
- 6.
- 7. 余淳, 罗琳, 杨翠, 等. 高质量发展背景下的大型综合医院人力资源合理配置. 成都: 四川大学出版社, 2024.
- 8.
- 9.
- 10. 国务院办公厅. 关于进一步深化基本医疗保险支付方式改革的指导意见(国办发〔2017〕55号). 2017.
- 11.
- 12.
- 13.
Journal type citation(12)
1. | 毛进璞. 老年慢性阻塞性肺疾病急性加重期合并肺栓塞患者中性粒细胞与淋巴细胞比值、红细胞分布宽度水平观察. 大医生. 2025(01): 116-118 . Baidu Scholar | |
2. | 鲜海英,何清华. 高原地区COPD合并肺心病的风险因素及其与血清hs-CRP、NT-proBNP、TNF-α的关系. 川北医学院学报. 2024(01): 63-66+83 . Baidu Scholar | |
3. | 王鹏程,袁林栋,许文娟,赵培革. 慢性阻塞性肺疾病急性加重严重程度评估研究进展. 中国呼吸与危重监护杂志. 2024(03): 206-210 . Baidu Scholar | |
4. | 宋玉良,王永. 慢性阻塞性肺疾病急性加重患者外周血红细胞分布宽度、嗜酸性粒细胞、B型钠尿肽的诊断价值及相关性分析. 分子诊断与治疗杂志. 2024(05): 890-893+903 . Baidu Scholar | |
5. | 张春红,程波,曹建. 细菌性肺炎患者血清LTB4、NLCR及CRP/PA变化及其与肺损伤程度的关系. 中南医学科学杂志. 2024(04): 596-598+672 . Baidu Scholar | |
6. | 张灵,杨荀,蒋水平,李小华. 老年慢性阻塞性肺疾病诊断与治疗新进展. 中华肺部疾病杂志(电子版). 2023(02): 285-289 . Baidu Scholar | |
7. | 唐小波,宋霜,周胃雯,林先珍,李香花,陈莹晖. 外周血NLR、Fib对老年慢性阻塞性肺疾病稳定期患者急性发作的预测价值. 中国老年学杂志. 2023(15): 3670-3673 . Baidu Scholar | |
8. | 刘亚敏,王建伟,吕建华. 血清PCT、NT-proBNP、WBC检测对重症慢性阻塞性肺疾病患者疾病转归的预测价值. 临床医学. 2023(08): 44-46 . Baidu Scholar | |
9. | 刁盛博,郑亚妹,邓国民. 茚达特罗格隆溴铵对慢性阻塞性肺疾病急性加重期患者肺功能及血清炎性因子的影响. 中国药业. 2023(17): 97-100 . Baidu Scholar | |
10. | 宗明园,过茜娜. NLR联合Fib预测慢性阻塞性肺疾病急性加重期住院死亡. 国际老年医学杂志. 2023(05): 565-569 . Baidu Scholar | |
11. | 柴卫芳,段小凯,樊实真,余勇,田金亚,侯俊飞. RDW/ALB值对COPD急性加重期患者临床预后的预测分析. 河南医学研究. 2023(24): 4456-4460 . Baidu Scholar | |
12. | 王婧雯,孙辉,路尧. 血清IL-33表达水平对慢性阻塞性肺疾病患者发生急性加重的预测价值. 齐齐哈尔医学院学报. 2022(18): 1732-1735 . Baidu Scholar | |
Other types of references(4)
1. | 李静. FAR、NLR、PLR在慢阻肺急性加重期的应用价值[D]. 河南大学. 2023. Baidu Scholar | |
2. | 刘欢. 慢性阻塞性肺疾病急性加重诊断模型的建立与验证研究[D]. 重庆医科大学. 2023. Baidu Scholar | |
3. | 刘佳丽. 红细胞分布宽度在慢性阻塞性肺疾病临床意义中的Meta分析[D]. 山西医科大学. 2023. Baidu Scholar | |
4. | 王鹏程. 探究SPO_2、SII、PLR、NLR在预测AECOPD患者全因住院死亡率中的价值[D]. 青岛大学. 2024. Baidu Scholar | |